文献速递流行病学与生物统计真实世界研究与卫生经济基础与转化研究

基于计数与聚类定义的多病共存比较及其与患病率、健康特征和死亡率的关系:英国生物银行队列研究

Comparison of count-based and clustering definitions of multimorbidity and their association with prevalence of multimorbidity, health profiles, and mortality: A cohort study of UK Biobank participants.
PubMed 文献 · PLoS Med · 2026-06-12

研究基于英国生物银行474,397名参与者的基线数据,比较了六种基于计数的多病共存定义与聚类分析对患病率、健康特征及死亡风险的影响。结果显示,多病共存患病率从1.0%(聚类法)到35.3%(计数法)不等,计数法定义与死亡风险的关联更稳健,聚类分析则提供了多病共存人群异质性的补充信息。

要点

  • 多病共存患病率因操作定义不同差异显著,计数法范围1.0%至35.3%。
  • 较高阈值识别出更严重的健康特征,但未显示更高死亡风险。
  • 聚类分析识别出低患病率但高死亡风险的亚组,提供互补信息。

核心结论

  • 多病共存的操作定义显著影响患病率估计,而计数法与死亡风险的关联较为稳健。
  • 聚类分析可揭示多病共存人群内部的异质性,提供补充见解。
  • 未来需转化研究以优化多病共存定义,改善临床管理和健康结局。

研究设计与样本

  • 基于英国生物银行2006至2010年基线数据的队列研究,样本量n=474,397。
  • 比较六种基于计数的多病共存定义(不同疾病列表和阈值≥2或≥3)。
  • 对至少患两种慢性病的参与者进行聚类分析以表征亚型。
  • 分别对男性和女性进行多变量回归模型分析,调整社会人口学特征和体重指数。

主要发现

  • 多病共存患病率范围从1.0%(聚类法)到35.3%(计数法)。
  • 使用包含更多疾病的列表的计数法定义产生更高患病率。
  • 较高阈值在所有测量的健康结局和血液指标上识别出更严重的健康特征,但未显示更高死亡风险。
  • 聚类分析与血液指标的关联更明显,与标准定义的差异最大分布在各个聚类中。
  • 3年死亡风险的比值比:男性1.44 [1.26; 1.64]至4.60 [3.73; 5.62],女性1.35 [1.07; 1.69]至3.83 [2.78; 5.14]。

临床怎么用

  • 临床和研究中选择多病共存定义时需注意其对患病率估计的显著影响。
  • 计数法定义与死亡风险的关联较为稳健,可用于风险分层。
  • 聚类分析可补充识别低患病率但高死亡风险的多病共存亚组。

局限性

  • 英国生物银行队列具有选择性,可能影响结果的普遍性。
  • 部分健康指标为横断面评估,无法确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multimorbidity, the presence of several chronic conditions, is linked to higher mortality and healthcare use and thus poses a major challenge for aging populations. While most studies rely on simple counts of conditions, clustering approaches have been proposed to describe patterns of co-occurring diseases. We aimed to evaluate the extent to which these methodological choices influence prevalence and association with health profiles and mortality. METHODS AND FINDINGS: Using UK Biobank baseline data (n = 474,397), collected between 2006 and 2010, we compared six count-based definitions of multimorbidity based on different condition lists (extended, most prevalent, or body systems) and thresholds (≥2 versus ≥3 conditions). We also applied a clustering analysis to characterize subtypes of multimorbidity among participants with at least two chronic conditions. We compared prevalence and associations with concurrent health outcomes (polypharmacy, self-rated health, frailty, falls, surgery, chronic pain), blood-based measures (C-reactive protein, Cystatin-C, HDL, LDL Cholesterol, IGF-1), and 3- and 10-year mortality risks. Analyses were undertaken separately in men and women using multivariable regression models adjusted for sociodemographic characteristics and body mass index. Multimorbidity prevalence ranged from 1.0% (cluster-based) to 35.3% (count-based). Count-based definitions using lists with more conditions yielded higher prevalence. Higher thresholds identified more severe health profiles on all measured health outcomes, blood-based measures, but not higher mortality risks. Associations with blood-based measures were more pronounced using clustering, with the highest differences from the standard definition distributed across clusters. Odds ratios for 3-year mortality ranged from 1.44 [1.26; 1.64] to 4.60 [3.73; 5.62] for men and 1.35 [1.07; 1.69] to 3.83 [2.78; 5.14] for women. For 10-year mortality, they ranged from 1.42 [1.34; 1.50] to 3.86 [3.46; 4.30] in men and 1.29 [1.21; 1.39] to 3.33 [2.93; 3.77] for women, with clustering identifying groups with low prevalence and high mortality risks. Findings should be interpreted in light of the selected nature of the UK Biobank cohort and the cross-sectional assessment of several health indicators. CONCLUSION: Operational definitions of multimorbidity substantially influence prevalence estimates, while associations with mortality appear more robust across count-based approaches. Clustering analyses provide complementary insights into heterogeneity within multimorbid populations. Future translational studies are warranted to determine how multimorbidity definitions can be optimized to ultimately improve clinical management and health outcomes in practice.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Silva GC, Fayosse A, Jacob L, et al. Comparison of count-based and clustering definitions of multimorbidity and their association with prevalence of multimorbidity, health profiles, and mortality: A cohort study of UK Biobank participants. PLoS Med. 2026. PMID: 42284367. doi:10.1371/journal.pmed.1004914

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。